The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity

by Masin Dana, Kierkels Guido JJ, Kapanen Anita I, Baker Jennifer HE, Franssen Yannick, Wong Ling, Qadir Mohammed A, Weppler Sherry A, Dragowska Wieslawa H, Minchinton Andrew I, Gelmon Karen A, Bally Marcel B
Published 2011-10-01